NTRR Considers Cannabis Cures for the Common Cold

  NTRR Considers Cannabis Cures for the Common Cold

Business Wire

TAMPA, Fla. -- March 1, 2013

As more and more North American markets approve the legalization of cannabis
for medicinal and therapeutic purposes, Neutra Corp. (OTCBB: NTRR) is
exploring the potential for new natural remedies derived from the
misunderstood plant.

The benefits of cannabis in the treatment of maladies from glaucoma to nausea
have long been understood, But with many new markets now opening up,
cannabinoids—the key chemical compounds found in marijuana plants—are now
being tested in topical ointments, pills and other treatments to cure
everything from skin ailments to digestive issues.

“In many ways, cannabis may prove to be the ultimate nutraceutical,” said NTRR
CEO Cindy Morrissey. “Our company is tremendously excited to explore
cannabinoids’ natural potential to ease suffering, especially because the
market for such remedies is booming from California to Massachusetts.”

Neutra Corp. plans to follow in the footsteps of other successful public
companies, including Cannibis Science, Inc. (OTCBB: CBIS) and Terra Tech Corp.
(OTCBB: TRTC), enabling agricultural advancements in the urban cultivation of
cannabis in approved markets.

“We’re ready to put the healing potential of cannabis into the hands of those
who need it most,” Morrissey said.

The company is also pursuing innovations in anti-microbial coatings for
surfaces in hospitals and other public spaces. Neutra Corp. is dedicated to
commercializing innovative, all-natural products to compete in the
fast-growing wellness sector alongside Herbalife Ltd. (NYSE:HLF) and
Nutraceutical International Corp. (NASDAQ:NUTR).

For more information on NTRR’s nutraceuticals initiative, please visit

Follow NTRR on Twitter atwww.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp.(www.neutracorp.com) is a healthy lifestyle company that
specializes in the development and marketing of natural wellnesssolutions.
The company is currently working to produce a full range of non-toxic products
to address every component of a healthy lifestyle. For investing information
and performance data, please visitwww.neutracorp.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including statements
that include the words "believes," "expects," "anticipate" or similar
expressions. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the company to differ materially from those expressed or
implied by such forward-looking statements. In addition, description of
anyone's past success, either financial or strategic, is no guarantee of
future success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information included
herein for events occurring after the date hereof.


Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO
Press spacebar to pause and continue. Press esc to stop.